EXIM Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-11-27
Share capital
100 000,00 PLN
Activity description

EXIM Pharma provides contract manufacturing of dietary supplements, medical devices and nutritional products for people and animals, including private-label brands. Its range includes probiotics in drops and capsules, vitamins, herbal preparations, tablets, hard and soft capsules, and hard capsules with liquid fillings. Products are made from customer-supplied recipes or the company’s own formulas, with additional services including encapsulation, tableting, coating, and product notification and registration.

Registered address
ul. Ogrodowa 37/50, 00-873 Warszawa, Poland
Website
eximpharma.euWebsite active
Phone
Social media
Electronic delivery address
AE:PL-21937-30159-SRWUS-25

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 24.69mMedianUSD 822.24kAverageUSD 24.19m
Net profit
This companyUSD 3.60mMedianUSD 8.57kAverageUSD 2.60m
Operating costs
This companyUSD 20.01mMedianUSD 721.37kAverageUSD 19.98m
Assets
This companyUSD 19.83mMedianUSD 800.34kAverageUSD 29.30m

Bank accounts

Registered as a VAT taxpayer on 2015-12-10. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

19 public aid cases recorded, with a total value of $1,402,769.

PurposeGross amount
Regional investment aid
$206.7K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$858
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,253

European Funds

ProjectEU co-financing
Promocja firmy Exim Pharma na rynkach zagranicznych w związku z udziałem Polski w Expo 2020
$56,907
Rozwój przedsiębiorstwa EXIM PHARMA poprzez promocję na rynkach międzynarodowych.
$87,120

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Agata Załęska — Attorney-in-fact (joint)
Igor Matus — Management Board Member
Marcus Kaiser — Attorney-in-fact (joint)
Michał Krzywina — Management Board Member

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Sunday Natural Products Gmbh
2,000$27,012.43100%

Beneficial owners

Person
Jörg Matthias Schweikart (58)

Change history

DateEvent
2022-12-08PKD change
2021-08-18Share capital change
2015-11-27Entered in the register

FAQ

Last updated: 2026-06-19